Stay updated with breaking news from Testing Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
STONY BROOK, NY / ACCESSWIRE / May 28, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced the pricing of a public
Shares of Applied DNA Sciences, Inc. (APDN) tanked over 65% on Tuesday morning after the company announced the pricing of $12 million public offering. APDN is currently trading at $0.
StockNews.com initiated coverage on shares of Applied DNA Sciences (NASDAQ:APDN – Free Report) in a report issued on Thursday. The firm issued a hold rating on the technology company’s stock. Separately, HC Wainwright increased their price objective on Applied DNA Sciences from $1.50 to $7.00 and gave the stock a buy rating in a research […]
StockNews.com assumed coverage on shares of Applied DNA Sciences (NASDAQ:APDN – Free Report) in a research report released on Thursday. The firm issued a hold rating on the technology company’s stock. Separately, HC Wainwright lifted their target price on shares of Applied DNA Sciences from $1.50 to $7.00 and gave the company a buy rating […]
Press release - Verified Market Reports - Lancets Market Analysis By Top Keyplayers - Roche, Lifescan, BD, Bayer, Abbott, B. Braun, ARKRAY, Terumo, I-SENS, Nipro, Omron, Infopia, AgaMatrix, Smiths Medical, Sarstedt, SANNUO, Yicheng, Yuwell, Greiner Bio One, Edan, Narang Medical - published on openPR.com